The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Squalene Synthase, a Determinant of Raft-associated Cholesterol and Modulator of Cancer Cell Proliferation
Open accessAbstract
Several cues for cell proliferation, migration, and survival are transmitted through lipid rafts, membrane microdomains enriched in sphingolipids and cholesterol. Cells obtain cholesterol from the circulation but can also synthesize cholesterol de novo through the mevalonate/isoprenoid pathway. This pathway, however, has several branches and also produces non-sterol isoprenoids. Squalene synthase (SQS) is the enzyme that determines the switch toward sterol biosynthesis. Here we demonstrate that in prostate cancer cells SQS expression is enhanced by androgens, channeling intermediates of the mevalonate/isoprenoid pathway toward cholesterol synthesis. Interestingly, the resulting increase in de novo synthesis of cholesterol mainly affects the cholesterol content of lipid rafts, while leaving non-raft cholesterol levels unaffected. Conversely, RNA interference-mediated SQS inhibition results in a decrease of raft-associated cholesterol. These data show that SQS activity and de novo cholesterol synthesis are determinants of membrane microdomain-associated cholesterol in cancer cells. Remarkably, SQS knock down also attenuates proliferation and induces death of prostate cancer cells. Similar effects are observed when cancer cells are treated with the chemical SQS inhibitor zaragozic acid A. Importantly, although the anti-tumor effect of statins has previously been attributed to inhibition of protein isoprenylation, the present study shows that specific inhibition of the cholesterol biosynthesis branch of the mevalonate/isoprenoid pathway also induces cancer cell death. These findings significantly underscore the importance of de novo cholesterol synthesis for cancer cell biology and suggest that SQS is a potential novel target for antineoplastic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The encoded protein is the first enzyme in cholesterol biosynthesis and catalyzes the dimerization of two molecules of farnesyl diphosphate via a two-step reaction to form squalene32, which plays an important role in cholesterol biosynthesis33,34.”
From RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression (2020) · cites this paper as [32]
In the citing paper
“Farnesyl-diphosphate farnesyltransferase 1 (FDFT1) encodes a membrane-associated enzyme acting at a branch point in the mevalonate pathway.”
From RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression (2020) · cites this paper as [32]
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Membrane lipid composition and cellular function.
Spector, A. A., & Yorek, M. A. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34276-0 · Cited by 1,495
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246
Demierre, M., Higgins, P., Gruber, S. B., Hawk, E. T., & Lippman, S. M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1751 · Cited by 833
Lipid rafts: contentious only from simplistic standpoints
Hancock, J. F. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1925 · Cited by 788
Flagged first, then by citations
Research works printed but not linked: 5
- Brown, 1973, Fed. Proc., 32, 2168
- Haeffner, 1984, Cancer Res., 44, 2668
- Marcelli, 1998, Cancer Res., 58, 76
- Swinnen, 1997, Cancer Res., 57, 1086
- De Schrijver, 2003, Cancer Res., 63, 3799
Cited by
Sorted by citations
Items 101–117 of 117
Papel del colesterol mitocondrial en la resistencia del carcinoma hepatocelular a la quimioterapia
Boronat, M., & José, J. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Importância da via do mevalonato nas neoplasias do córtex adrenal
Valassi, H. P. L. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-18022011-122810
Fessler, M. B., & Parks, J. S. (2013)
Molecular Modeling in Drug Design
Wade, R. C., & Salo‐Ahen, O. M. H. (2019) · MDPI eBooks · doi:10.3390/books978-3-03897-615-8
Castro, M. A. (2019) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/72425
Rôle du cholestérol et des récepteurs nucléaires LXRs dans le cancer de la prostate
Pommier, A. (2010) · theses.fr (ABES) · doi:10.70675/0c05694fzc641z454cz8ea3z1193cb115d99
(2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32831b7581
Liquid Biopsy in non-small cell lung cancer: exosomes as a tool for the study of biomarkers.
Sáez, M. E. D. (2024) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/203438
Zhao, S.-C., Wen, B., Gao, J., & Chen, Z. (2024) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2024.101314
Mo, J., Lamichhane, S., Sharma, G., & Chae, S. (2025) · Gastroenterology Insights · doi:10.3390/gastroent16010005
Interplay of nutrient stress and lipid dynamics in colorectal cancer cells
Kousar, S., Gull, S., Aqeel, M. B., Shah, F. I., Mahjabeen, I., Shahid, A., Shoaib, N., & Khan, Z. (2025) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2025.01.005
AQP1/4, CLIC5 dysregulation and lipid metabolism alterations in lung cancer
Bae, H.-S., & Cho, J. (2026) · BMB Reports · doi:10.5483/bmbrep.2024-0160
Asperger, H., Stamm, N., Gierke, B., Pawlak, M., Hofmann, U., Zanger, U. M., Marton, A., Katona, R. L., Buhala, A., Vízler, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12650446
NR2F2/AGAP2 axis: regulating lipid synthesis to drive AML progression via AMPKα/ACC pathway
Xin, Q., Zhang, H., Zhao, Z., Xu, G., & Zhang, J. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01184-8
Yen, J.-H., Phan, T. Q., Liou, J.-W., & Chen, P.-Y. (2026) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj-d-26-00039
Metadata
- Authors
- Brusselmans, K., Timmermans, L., Van de Sande, T., Van Veldhoven, P. P., Guan, G., Shechter, I., Claessens, F., Verhoeven, G., & Swinnen, J. V.
- Affiliations
- KU Leuven (BE)
- Uniformed Services University of the Health Sciences (US)
- Corresponding author
- Swinnen, Johannes V.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 282
- Issue
- 26
- Pages
- 18777-18785
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2136706193
- Cited by
- 116
- References
- 49
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 4 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 8
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Keywords
- squalene synthase, cholesterol biosynthesis, lipid rafts, prostate cancer, androgens, tumor cell proliferation, cancer cell death, statins, zaragozic acid A, sterol biosynthesis
- MeSH terms
- Acetates, Androgens, Carbon Radioisotopes, Cell Division, Cholesterol, Detergents, Enzyme Inhibitors, Humans, Male, Promoter Regions, Genetic, Prostatic Neoplasms, RNA, Messenger, Farnesyl-Diphosphate Farnesyltransferase, Terpenes, Tricarboxylic Acids, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Cell Death, Bridged Bicyclo Compounds, Heterocyclic, Membrane Microdomains, RNA, Small Interfering, Cell Line, Tumor, Sterol Regulatory Element Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review